| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61314-308-02 | 61314-308 | HUMAN PRESCRIPTION DRUG | Azelastine Hydrochloride | azelastine hydrochloride | SOLUTION/ DROPS | INTRAOCULAR | 20130321 | N/A | ANDA | ANDA202305 | Sandoz Inc | AZELASTINE HYDROCHLORIDE | .5 mg/mL | 1 BOTTLE, PLASTIC in 1 CARTON (61314-308-02) / 6 mL in 1 BOTTLE, PLASTIC |
| 53002-1803-1 | 53002-1803 | HUMAN PRESCRIPTION DRUG | Azelastine Hydrochloride | azelastine hydrochloride | SOLUTION/ DROPS | INTRAOCULAR | 20220601 | N/A | ANDA | ANDA202305 | RPK Pharmaceuticals, Inc. | AZELASTINE HYDROCHLORIDE | .5 mg/mL | 1 BOTTLE, PLASTIC in 1 CARTON (53002-1803-1) / 6 mL in 1 BOTTLE, PLASTIC |